Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04788212 · ClinicalTrials.gov registry record · NA
Transdiagnostic Group Behavioral Activation for Autistic Adults
A NA study, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT04788212 is a NA study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 6 participants.
The verdict
NCT04788212, a NA study, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the feasibility, acceptability and effectiveness of a telehealth Group Behavioral Activation Therapy (GBAT) for autistic adults.
Interventions
- BEHAVIORAL Group Behavioral Activation Therapy for Autism Spectrum Disorder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2021-02-16 |
| Est. Completion | 2021-07-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04788212
The ClinicalTrials.gov registry entry for NCT04788212 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Group Behavioral Activation Therapy for Autism Spectrum Disorder is the first listed.
NCT04788212 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04788212 about?
NCT04788212 is a clinical study titled "Transdiagnostic Group Behavioral Activation for Autistic Adults". The purpose of this study is to evaluate the feasibility, acceptability and effectiveness of a telehealth Group Behavioral Activation Therapy (GBAT) for autistic adults.
What is the current status of trial NCT04788212?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2021-02-16. Estimated completion is 2021-07-08.
What interventions are being tested in trial NCT04788212?
The interventions under investigation include: Group Behavioral Activation Therapy for Autism Spectrum Disorder (BEHAVIORAL).
Who is sponsoring clinical trial NCT04788212?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.